Meeting of the National Vaccine Advisory Committee, 43131-43132 [E9-20572]

Download as PDF Federal Register / Vol. 74, No. 164 / Wednesday, August 26, 2009 / Notices Dated: August 21, 2009. Karen V. Gregory, Secretary. [FR Doc. E9–20608 Filed 8–25–09; 8:45 am] 43131 GENERAL SERVICES ADMINISTRATION NATIONAL AERONAUTICS AND SPACE ADMINISTRATION [OMB Control No. 9000–0095] Federal Acquisition Regulation; Submission for OMB Review; Commerce Patent Regulations jlentini on DSKJ8SOYB1PROD with NOTICES AGENCIES: Department of Defense (DOD), General Services Administration (GSA), and National Aeronautics and Space Administration (NASA). ACTION: Notice of request for comments regarding the reinstatement of a previously existing OMB clearance. SUMMARY: Under the provisions of the Paperwork Reduction Act of 1995 (44 U.S.C. Chapter 35), the Federal Acquisition Regulation (FAR) Secretariat will be submitting to the Office of Management and Budget (OMB) a request to review and approve a reinstatement of a previously approved information collection requirement concerning Commerce Patent Regulations. Public comments are particularly invited on: Whether this collection of information is necessary; whether it will have practical utility; whether our estimate of the public burden of this collection of information is accurate, and based on valid assumptions and methodology; ways to enhance the quality, utility, and clarity of the information to be collected; and ways in which we can minimize the burden of the collection of information on those who are to respond, through the use of appropriate technological collection techniques or other forms of information technology. DATES: Submit comments on or before September 25, 2009. ADDRESSES: Submit comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden, to: General Services Administration (GSA), Regulatory Secretariat (VPR), 1800 F Street, NW., Room 4041, Washington, DC 20405. Please cite OMB Control No. 9000–0095, Commerce Patent Regulations, in all correspondence. 17:05 Aug 25, 2009 Jkt 217001 AGENCY: Department of Health and Human Services, Office of the Secretary, Office of Public Health and Science. ACTION: Notice of meeting. A. Purpose DEPARTMENT OF DEFENSE VerDate Nov<24>2008 DEPARTMENT OF HEALTH AND HUMAN SERVICES SUPPLEMENTARY INFORMATION: BILLING CODE 6730–01–P FOR FURTHER INFORMATION CONTACT: Mr. Ernest Woodson, Procurement Analyst, Contract Policy Division, GSA, (202) 501–3775 or e-mail ernest.woodson@gsa.gov. As a result of the Department of Commerce (Commerce) publishing a final rule in the Federal Register implementing Pub. L. 98–620 (52 FR 8552, March 18, 1987), a revision to FAR Subpart 27.3 to implement the Commerce regulation was published in the Federal Register as an interim rule on June 12, 1989 (54 FR 25060). The final rule was published without change on June 21, 1990. A Government contractor must report all subject inventions to the contracting officer, submit a disclosure of the invention, and identify any publication, or sale, or public use of the invention (52.227–11(c), 52.227–13(e)(1). The contracting officer may modify 52.227– 11(e) or otherwise supplement the clause to require contractors to submit periodic or interim and final reports listing subject inventions (27.303(b)(2)(i) and (ii)). In order to ensure that subject inventions are reported, the contractor is required to establish and maintain effective procedures for identifying and disclosing subject inventions (52.227– 11, Alternate IV; 52.227–13(e)(1)). In addition, the contractor must require his employees, by written agreements, to disclose subject inventions (52.227– 11(e)(2); 52.227–13(e)(4)). The contractor also has an obligation to utilize the subject invention, and agree to report, upon request, the utilization or efforts to utilize the subject invention (27.302(e); 52.227–11(f). B. Annual Reporting Burden Respondents: 1,200. Responses per Respondent: 9.75. Total Responses: 11,700. Hours per Response: 3.9. Total Burden Hours: 45,630. Obtaining Copies of Proposals: Requesters may obtain a copy of the information collection documents from the General Services Administration (GSA), Regulatory Secretariat (VPR), 1800 F Street, NW., Room 4041, Washington, DC 20405, telephone (202) 501–4755. Please cite OMB Control No. 9000–0095, Commerce Patent Regulations, in all correspondence. Dated: August 20, 2009. Al Matera, Director, Office of Acquisition Policy. [FR Doc. E9–20517 Filed 8–25–09; 8:45 am] Meeting of the National Vaccine Advisory Committee SUMMARY: As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that the National Vaccine Advisory Committee (NVAC) will hold a meeting. The meeting is open to the public. Preregistration is required for both public attendance and comment. Individuals who wish to attend the meeting and/or participate in the public comment session should e-mail nvpo@hhs.gov, call 202–690–5566, or complete the online form on the NVAC Web site (https:// www.hhs.gov/nvpo/nvac/.) to register. DATES: The meeting will be held on September 15, 2009, from 9 a.m. to 5:30 p.m. and on September 16, 2009, from 8:30 a.m. to 1:30 p.m. ADDRESSES: Department of Health and Human Services; Hubert H. Humphrey Building, Room 800; 200 Independence Avenue, SW., Washington, DC 20201. FOR FURTHER INFORMATION CONTACT: Ms. Andrea Krull, Public Health Advisor, National Vaccine Program Office, Department of Health and Human Services, Room 715–H Hubert H. Humphrey Building, 200 Independence Avenue, SW., Washington, DC 20201. Phone: (202) 690–5566; Fax: (202) 260– 1165; e-mail: nvpo@hhs.gov. SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public Health Service Act (42 U.S.C. Section 300aa–1), the Secretary of Health and Human Services was mandated to establish the National Vaccine Program to achieve optimal prevention of human infectious diseases through immunization and to achieve optimal prevention against adverse reactions to vaccines. The National Vaccine Advisory Committee was established to provide advice and make recommendations to the Director of the National Vaccine Program, on matters related to the Program’s responsibilities. The Assistant Secretary for Health serves as Director of the National Vaccine Program. Topics to be discussed at the meeting include vaccine safety working group activity, the National Vaccine Plan, implementation plans for recent NVAC recommendations, financial considerations for adult immunizations, BILLING CODE 6820–EP–P PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 E:\FR\FM\26AUN1.SGM 26AUN1 43132 Federal Register / Vol. 74, No. 164 / Wednesday, August 26, 2009 / Notices seasonal influenza, and issues related to the 2009 H1N1 influenza response and vaccine development. The meeting agenda will be posted on the NVAC Website: https://www.hhs.gov/nvpo/nvac by August 31, 2009. Public attendance at the meeting is limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the designated contact person at least one week prior to the meeting. Members of the public will have the opportunity to provide comments at the meeting. Public comment will be limited to three to five minutes per speaker. Individuals who would like to submit written statements should e-mail or fax their comments to the National Vaccine Program Office at least five business days prior to the meeting. Register by sending an e-mail to nvpo@hhs.gov, or by calling 202–690–5566, or by completing the on-line registration form at https://www.hhs.gov/nvpo/nvac and providing name, e-mail address and organization. Dated: August 19, 2009. Bruce Gellin, Deputy Assistant Secretary for Health, Director, National Vaccine Program Office. [FR Doc. E9–20572 Filed 8–25–09; 8:45 am] BILLING CODE 4150–44–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Solicitation of Nominations for Membership on the Presidential Advisory Council on HIV/AIDS AGENCY: Department of Health and Human Services, Office of the Secretary, Office of Public Health and Science. ACTION: Notice. Executive Order 12963, dated June 14, 1995, as amended by Executive Order 13009, dated June 14, 1996; and Section 222 of the Public Health Service Act (42 U.S.C. 217a). The Council is governed by the provisions of Public Law 92–463, as amended (5 U.S.C. App), which sets forth standards for the formation and use of advisory committees. SUMMARY: The Office of HIV/AIDS Policy (OHAP), a program office within the Office of Public Health and Science, Department of Health and Human Services (HHS), is soliciting nominations of qualified candidates to be considered for appointment as members to the Presidential Advisory Council on HIV/AIDS (PACHA). The activities of this council are governed by jlentini on DSKJ8SOYB1PROD with NOTICES AUTHORITY: VerDate Nov<24>2008 17:05 Aug 25, 2009 Jkt 217001 the Federal Advisory Committee Act (FACA). Management support for the activities of this Council is the responsibility of the OHAP. The Council provides advice, information, and recommendations to the Secretary of Health and Human Services regarding programs and policies to promote effective prevention and cure of HIV disease and AIDS. The functions of the Council shall be solely advisory in nature. DATES: All nominations for membership on the Council must be received no later than September 11, 2009. ADDRESSES: All nominations should be mailed or delivered to: Christopher Bates, Director, OHAP, Office of Public Health and Science, Department of Health and Human Services, 200 Independence Avenue, SW., Room 443– H, Hubert H. Humphrey Building; Washington, DC 20201. FOR FURTHER INFORMATION CONTACT: Mr. Melvin Joppy, Program Specialist, Office of HIV/AIDS Policy, Department of Health and Human Services, 200 Independence Avenue, SW., Room 443– H, Hubert H. Humphrey Building, Washington, DC 20201; (202) 690–5560; melvin.joppy@hhs.gov. A copy of the charter which includes the Council’s structure and functions can be obtained by contacting Mr. Joppy or by accessing the PACHA Web site at https://www.pacha.gov. SUPPLEMENTARY INFORMATION: Committee Function, Qualifications, and Information Required: The Council consists of not more than 25 members; one or more members are selected as Chair, Vice Chair and/or Co-Chairs. Council members are selected from prominent community leaders with particular expertise in, or knowledge of, matters concerning HIV/AIDS, public health, global health, philanthropy, marketing or business, as well as other national leaders held in high esteem from other sectors of society. Council members, as well as the Council leadership, are appointed by the Secretary or designee, in consultation with the White House Office of National AIDS Policy. All Council members are classified as special Government employees (SGEs). The Council composition may include ex officio members from relevant HHS components, as deemed necessary to accomplish the established mission of the Council. Council members are invited to serve for overlapping terms of up to four years; terms are contingent upon the authorized continuation of the Council. A member can serve after the expiration of their term until their successor has PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 taken office and/or until notified in writing that their term has ended or expired, but no longer than 180 days. Pursuant to advance written agreement, Council members receive no stipend for the advisory service they render as members of PACHA. However, as authorized by law and in accordance with Federal travel regulations, PACHA members receive per diem and reimbursement for travel expenses incurred in relation to performing duties for the Council. With approval of the Secretary or designee, subcommittees may be established to perform specific functions within the jurisdiction of the Council. Compositions for the subcommittee are members of the Council. The subcommittees make preliminary recommendations to be considered by the Council membership. Nominations In accordance with the charter, persons nominated for appointment as members of the PACHA should be prominent community leaders or national leaders who are held in high esteem from other sectors of society with particular expertise in, or knowledge of, matters concerning HIV and AIDS, public health, global health, philanthropy, and marketing or business. Nominations should be typewritten. The following information should be included in the package of material submitted for each individual being nominated for consideration: (1) A letter of nomination that clearly states the name and affiliation of the nominee, the basis for the nomination (i.e., specific attributes which qualify the nominee for service in this capacity); (2) a statement from the nominee, bearing an original signature, that, if appointed, he or she is willing to serve as a member of the Council; (3) the nominator’s name, address and daytime telephone number, and the home and/or work address, telephone number, and email address of the individual being nominated; and (4) a current copy of the nominee’s curriculum vitae. Individuals can nominate themselves for consideration of appointment to the Council. All nominations must include the required information. Incomplete nominations will not be processed for consideration. The letter from the nominator and certification of the nominated individual must bear original signatures; reproduced copies of these signatures are not acceptable. Applications cannot be submitted by facsimile. The names of Federal employees should not be nominated for consideration of appointment to this Council. E:\FR\FM\26AUN1.SGM 26AUN1

Agencies

DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 74, Number 164 (Wednesday, August 26, 2009)]
[Notices]
[Pages 43131-43132]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-20572]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the National Vaccine Advisory Committee

AGENCY: Department of Health and Human Services, Office of the 
Secretary, Office of Public Health and Science.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that the National Vaccine Advisory Committee (NVAC) will hold a 
meeting. The meeting is open to the public. Pre-registration is 
required for both public attendance and comment. Individuals who wish 
to attend the meeting and/or participate in the public comment session 
should e-mail nvpo@hhs.gov, call 202-690-5566, or complete the on-line 
form on the NVAC Web site (https://www.hhs.gov/nvpo/nvac/.) to 
register.

DATES: The meeting will be held on September 15, 2009, from 9 a.m. to 
5:30 p.m. and on September 16, 2009, from 8:30 a.m. to 1:30 p.m.

ADDRESSES: Department of Health and Human Services; Hubert H. Humphrey 
Building, Room 800; 200 Independence Avenue, SW., Washington, DC 20201.

FOR FURTHER INFORMATION CONTACT: Ms. Andrea Krull, Public Health 
Advisor, National Vaccine Program Office, Department of Health and 
Human Services, Room 715-H Hubert H. Humphrey Building, 200 
Independence Avenue, SW., Washington, DC 20201. Phone: (202) 690-5566; 
Fax: (202) 260-1165; e-mail: nvpo@hhs.gov.

SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public 
Health Service Act (42 U.S.C. Section 300aa-1), the Secretary of Health 
and Human Services was mandated to establish the National Vaccine 
Program to achieve optimal prevention of human infectious diseases 
through immunization and to achieve optimal prevention against adverse 
reactions to vaccines. The National Vaccine Advisory Committee was 
established to provide advice and make recommendations to the Director 
of the National Vaccine Program, on matters related to the Program's 
responsibilities. The Assistant Secretary for Health serves as Director 
of the National Vaccine Program.
    Topics to be discussed at the meeting include vaccine safety 
working group activity, the National Vaccine Plan, implementation plans 
for recent NVAC recommendations, financial considerations for adult 
immunizations,

[[Page 43132]]

seasonal influenza, and issues related to the 2009 H1N1 influenza 
response and vaccine development. The meeting agenda will be posted on 
the NVAC Website: https://www.hhs.gov/nvpo/nvac by August 31, 2009.
    Public attendance at the meeting is limited to space available. 
Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify the designated contact person at least one week prior to the 
meeting. Members of the public will have the opportunity to provide 
comments at the meeting. Public comment will be limited to three to 
five minutes per speaker. Individuals who would like to submit written 
statements should e-mail or fax their comments to the National Vaccine 
Program Office at least five business days prior to the meeting. 
Register by sending an e-mail to nvpo@hhs.gov, or by calling 202-690-
5566, or by completing the on-line registration form at https://www.hhs.gov/nvpo/nvac and providing name, e-mail address and 
organization.

    Dated: August 19, 2009.
Bruce Gellin,
Deputy Assistant Secretary for Health, Director, National Vaccine 
Program Office.
[FR Doc. E9-20572 Filed 8-25-09; 8:45 am]
BILLING CODE 4150-44-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.